1.16
price up icon2.65%   0.03
after-market After Hours: 1.14 -0.02 -1.72%
loading

Pliant Therapeutics Inc Stock (PLRX) Forecast

The Pliant Therapeutics Inc (PLRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.76, representing a +914.02% increase from the current price of $1.16. The highest analyst price target is $14.86, and the lowest is $8.6649.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PLRX Price Target
Average 19.24 (+1,558% Upside)
loading

Is Pliant Therapeutics Inc (PLRX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 59.89 Neutral
STOCH(9,6) 64.62 Neutral
STOCHRSI(14) 79.58 Neutral
MACD(12,26) 0.00881 Buy
ADX(14) 28.03 Buy
William %R -35.71 Neutral
CCI(14) 105.25 Buy
Buy: 3 Sell: 0 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.0985
Buy
1.112
Buy
MA20
1.0763
Buy
1.0978
Buy
MA50
1.1101
Buy
1.115
Buy
MA100
1.1728
Sell
1.1608
Sell
MA200
1.2509
Sell
1.2419
Sell
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, PLRX could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 4 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on PLRX, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 59.89 indicates that PLRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 64.62 indicates that PLRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 79.58 indicates that PLRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 28.03 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 105.25 indicates that PLRX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term PLRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Pliant Therapeutics Inc financial reports and earnings history, Pliant Therapeutics Inc (PLRX) stock could reach $11.86 by 2030, $21.58 by 2040 and $19.69 by 2050. See the projected annual prices until 2050 of the Pliant Therapeutics Inc stock below:

  • Pliant Therapeutics Inc (PLRX) is expected to reach an average price of $11.91 in 2035, with a high prediction of $11.64 and a low estimate of $11.14. This indicates an $926.63% rise from the last recorded price of $1.16.
  • Pliant Therapeutics Inc (PLRX) stock is projected to chart a bullish course in 2040, with an average price target of $9.3231, representing an $703.71% surge from its current level. The forecast ranges from a conservative $13.67 to a sky-high $21.58.
  • Our analysts predict Pliant Therapeutics Inc (PLRX) to jump 837.97% by 2045, soaring from $16.06 to an average price of $10.88, potentially reaching $15.14. While $16.06 is the low estimate, the potential upside is significant.
  • Pliant Therapeutics Inc (PLRX) stock is expected to climb by 2050, reaching an average of $19.78, a $1,606% jump from its current level. However, a wide range of estimates exists, with high and low targets of $19.69 and $18.06, respectively, highlighting the market's uncertainty.

Pliant Therapeutics Inc Stock (PLRX) Year by Year Forecast

Pliant Therapeutics Inc Stock (PLRX) Price Forecast for 2026

The predicted value for Pliant Therapeutics Inc (PLRX) in 2026 is set at an average of $8.8155. Estimates vary from a peak of $17.61 to a trough of $0.0236, indicating an +659.96% surge from the present price of $1.16.
Month Average Low High Change from today's price
October, 2026 $11.92 $8.6649 $14.86 +927.44%
November, 2026 $15.01 $10.75 $15.49 +1,194%
December, 2026 $15.45 $11.85 $17.61 +1,232%

Pliant Therapeutics Inc Stock (PLRX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Pliant Therapeutics Inc (PLRX) is $19.64, with a high forecast of $29.81 and a low forecast of $9.4668. This indicates an +1,593% increase from the last price of $1.16.
Month Average Low High Change from today's price
January, 2027 $15.36 $13.86 $19.15 +1,224%
February, 2027 $11.39 $10.51 $15.82 +882.00%
March, 2027 $12.43 $9.4668 $12.77 +971.58%
April, 2027 $28.04 $11.32 $29.81 +2,317%
May, 2027 $24.67 $23.07 $28.88 +2,027%
June, 2027 $20.43 $19.93 $25.57 +1,661%
July, 2027 $19.90 $17.61 $21.53 +1,616%
August, 2027 $15.56 $13.07 $24.29 +1,242%
September, 2027 $16.15 $14.17 $17.37 +1,293%
October, 2027 $12.00 $11.18 $18.32 +934.89%
November, 2027 $11.55 $10.46 $12.89 +895.35%
December, 2027 $10.68 $9.6573 $13.95 +820.27%

Pliant Therapeutics Inc Stock (PLRX) Price Forecast for 2028

In 2028, Pliant Therapeutics Inc (PLRX) is projected to reach an average price of $9.2313, with a high projection of $16.59 and a low estimate of $1.87. This indicates an +695.80% rise from the last price of $1.16.
Month Average Low High Change from today's price
January, 2028 $8.8764 $8.8464 $11.12 +665.20%
February, 2028 $7.5876 $7.1676 $11.93 +554.11%
March, 2028 $8.2067 $6.6317 $10.37 +607.48%
April, 2028 $8.728 $7.5102 $9.448 +652.41%
May, 2028 $12.09 $8.2558 $13.81 +941.99%
June, 2028 $11.66 $10.18 $13.16 +905.03%
July, 2028 $10.20 $7.6762 $12.33 +779.28%
August, 2028 $9.3187 $8.4887 $11.35 +703.33%
September, 2028 $6.2999 $5.6999 $9.6365 +443.10%
October, 2028 $3.7056 $1.87 $7.4056 +219.45%
November, 2028 $6.2038 $3.5453 $16.59 +434.81%
December, 2028 $7.0363 $3.0121 $9.4451 +506.58%

Pliant Therapeutics Inc Stock (PLRX) Price Forecast for 2029

The 2029 price forecast for Pliant Therapeutics Inc Stock (PLRX) is $13.63 on average, with a high prediction of $26.24 and a low estimate of $1.0327. This represents an +1,075% increase from the previous price of $1.16.
Month Average Low High Change from today's price
January, 2029 $4.6445 $4.4645 $8.112 +300.39%
February, 2029 $4.147 $1.5614 $13.37 +257.50%
March, 2029 $5.4096 $1.0327 $7.3096 +366.34%
April, 2029 $10.40 $1.1358 $11.34 +796.73%
May, 2029 $7.7802 $7.1746 $14.82 +570.71%
June, 2029 $8.2328 $4.5615 $10.32 +609.72%
July, 2029 $13.57 $6.174 $17.71 +1,069%
August, 2029 $21.60 $11.35 $26.24 +1,762%
September, 2029 $16.47 $16.27 $24.75 +1,319%
October, 2029 $10.79 $10.59 $18.60 +830.53%
November, 2029 $15.89 $10.77 $15.98 +1,270%
December, 2029 $11.15 $10.82 $16.87 +861.14%

Pliant Therapeutics Inc Stock (PLRX) Price Forecast for 2030

Pliant Therapeutics Inc Stock (PLRX) is expected to reach an average price of $5.9437 in 2030, with a high forecast of $11.86 and a low forecast of $0.0225. This signifies an +412.39% surge from the last price of $1.16.
Month Average Low High Change from today's price
January, 2030 $5.8374 $1.4518 $11.86 +403.22%
February, 2030 $1.5899 $0.7361 $7.368 +37.06%
March, 2030 $1.1725 $0.4926 $7.5912 +1.07%
April, 2030 $1.70 $0.158 $2.3381 +46.55%
May, 2030 $1.1868 $0.0225 $2.3406 +2.31%
June, 2030 $0.9343 $2.3412 $1.36 -19.46%
July, 2030 $3.1862 $1.496 $2.4862 +174.67%
August, 2030 $5.1736 $4.5593 $3.7593 +346.00%
September, 2030 $6.6111 $5.268 $5.8911 +469.92%
October, 2030 $8.3929 $6.9855 $7.4529 +623.53%
November, 2030 $8.0504 $8.3617 $8.2473 +594.00%
December, 2030 $10.16 $9.3748 $10.08 +775.68%
$103.76
price up icon 0.86%
$126.29
price down icon 0.31%
$63.96
price up icon 0.13%
$266.11
price up icon 0.61%
ONC ONC
$358.26
price down icon 1.22%
$210.02
price down icon 0.40%
Cap:     |  Volume (24h):